Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 15/20 | 0.52 |
| ▸ | MAPK13 | O15264 | 5/20 | 0.52 |
| ▸ | MAPK12 | P53778 | 5/20 | 0.52 |
| ▸ | MAPK11 | Q15759 | 5/20 | 0.52 |
| ▸ | CSNK1D | P48730 | 3/20 | 0.51 |
| ▸ | MAPK10 | P53779 | 3/20 | 0.51 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.51 |
| ▸ | GCGR | P47871 | 3/20 | 0.50 |
| ▸ | GSK3B | P49841 | 2/20 | 0.48 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.46 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.46 |
| ▸ | FRK | P42685 | 1/20 | 0.46 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.46 |
| ▸ | PTK6 | Q13882 | 1/20 | 0.46 |
| ▸ | PRKD2 | Q9BZL6 | 1/20 | 0.46 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.46 |
| ▸ | BRAF | P15056 | 1/20 | 0.45 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6934304 | 0.85 | MAPK14 (0.55) | MAPK14MAPK13MAPK12MAPK11CSNK1D | |
| SCHEMBL9646788 | 0.82 | MAPK14 (0.67) | MAPK14MAPK13MAPK12MAPK11CSNK1D | |
| SCHEMBL1387734 | 0.82 | MAPK14 (0.67) | MAPK14MAPK13MAPK12MAPK11CSNK1D | |
| SCHEMBL6933891 | 0.82 | MAPK14 (0.64) | MAPK14MAPK13MAPK12MAPK11CSNK1D | |
| SCHEMBL14064490 | 0.81 | MAPK14 (0.52) | MAPK14MAPK13MAPK12MAPK11CSNK1D | |
| SCHEMBL7071770 | 0.81 | XDH (0.61) | MAPK14MAPK13MAPK12MAPK11CSNK1D | |
| SCHEMBL6934771 | 0.80 | MAPK14 (0.67) | MAPK14MAPK13MAPK12MAPK11CSNK1D | |
| SCHEMBL6932744 | 0.77 | MAPK14 (0.67) | MAPK14MAPK13MAPK12MAPK11CSNK1D | |
| SCHEMBL6934609 | 0.77 | MAPK14 (0.51) | MAPK14MAPK13MAPK12MAPK11CSNK1D | |
| SCHEMBL9648774 | 0.73 | KDM4E (0.70) | MAPK14MAPK13MAPK12MAPK11CSNK1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6610698-B2 | Treatment of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6, and interleukin-8 mediated diseases | AMGEN, INC. | 2003-08-26 | — | — | US | disclosed |
| EP-1314732-A2 | Substituted pyrimidine compounds and their use | AMGEN INC. (US) | 2003-05-28 | — | — | EP | disclosed |
| EP-1314731-A2 | Substituted pyrimidine compounds and their use | AMGEN INC. (US) | 2003-05-28 | — | — | EP | disclosed |
| US-6420385-B1 | INFLAMMATORY, PAIN AND DIABETES DISEASES, | AMGEN INC. | 2002-07-16 | — | — | US | disclosed |
| US-6410729-B1 | ANALGESICS; ANTIDIABETIC AGENTS; ANTIINFLAMMATORY AGENTS | AMGEN INC. | 2002-06-25 | — | — | US | disclosed |
| US-6096753-A | Substituted pyrimidinone and pyridone compounds and methods of use | AMGEN INC. (US) | 2000-08-01 | — | — | US | disclosed |